核内レチノイド受容体を標的とした新規糖尿病性腎臓病治療薬の探索

• Project/Area Number: 20K16548
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 52010:General internal medicine-related
• Research Institution: The University of Tokushima
• Principal Investigator: 藤田 結衣 徳島大学, 大学院医歯薬学研究部(医学域), 徳島大学専門研究員 (30837266)
• Project Period (FY): 2020-04-01 – 2023-03-31
• Project Status: Declined (Fiscal Year 2020)
• Budget Amount: ¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000); Fiscal Year 2022: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000); Fiscal Year 2021: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000); Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)